LMR Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$15.5M Buy
+374,989
New +$16.3M 0.05% 316
2024
Q2
– Sell
-13,700
Closed -$666K – 1296
2024
Q1
$666K Hold
13,700
– – 0.01% 730
2023
Q4
$681K Hold
13,700
– – 0.01% 619
2023
Q3
$735K Hold
13,700
– – 0.01% 526
2023
Q2
$738K Buy
+13,700
New +$737K 0.01% 456
2022
Q2
– Sell
-53,180
Closed -$2.73M – 1452
2022
Q1
$2.73M Sell
53,180
-60,147
-53% -$3.11M 0.03% 470
2021
Q4
$5.68M Buy
113,327
+68,327
+152% +$3.38M 0.06% 242
2021
Q3
$2.17M Buy
+45,000
New +$2.29M 0.02% 433
2020
Q1
– Sell
-13,277
Closed -$667K – 421
2019
Q4
$667K Buy
+13,277
New +$622K ﹤0.01% 270

Other funds holding SNY

LMR Partners's SNY Position: Q3 2026 in Review

LMR Partners opened a new position in Sanofi (SNY) in Q3 2026: 374,989 shares worth $15.5M. The stake represents 0.05% of the portfolio and ranks #316 among its holdings. This is a return to the name: LMR Partners previously reported a position in SNY as recently as Q1 2024.

LMR Partners first reported a position in SNY in Q4 2019 and has held it in 9 quarters since. 687 funds tracked by Wall St. Rank hold SNY as of Q3 2026.

  • LMR Partners held 374,989 shares of Sanofi worth $15.5M as of Q3 2026.
  • Sanofi was a new LMR Partners position in Q3 2026.
  • Sanofi made up 0.05% of LMR Partners's portfolio in Q3 2026, its #316 holding.
  • LMR Partners first reported a position in Sanofi in Q4 2019 and has held it in 9 quarters since.
  • 687 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.